Skip to main content
Clinical Trials/DRKS00014313
DRKS00014313
Recruiting
未知

Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation - cTBS-AH

niversitätsklinikum Tübingen, Klinik für Psychiatrie und Psychotherapie0 sites86 target enrollmentMarch 22, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Auditory Hallucinations in the context of a schizophrenic diseaseDSM-5 295.90: Schizophrenia DisorderDSM-5295.40: Schizophreniform DisorderDSM-5 295.70: Schizoaffective Disorder
Sponsor
niversitätsklinikum Tübingen, Klinik für Psychiatrie und Psychotherapie
Enrollment
86
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 22, 2018
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Tübingen, Klinik für Psychiatrie und Psychotherapie

Eligibility Criteria

Inclusion Criteria

  • Men and women, age 18\-55 years
  • \- Schizophrenia (DSM\-5 295\.90\), schizophreniform disorder (DSM\-5, 295\.40\), or schizoaffective disorder (DSM\-5 295\.70\)
  • \- Auditory hallucinations (AH) present at least once a week, for at least 3 months
  • \- No sufficient effect of at least one adequate antipsychotic treatment
  • \- Severity according to PANSS hallucination score (Item P3\) of 3 or more
  • \- Fluent German language
  • \- Stable antipsychotic medication 4 weeks before and 3 weeks during the treatment.
  • Participants must have the capacity of consent and must be able to understand the subject information, to carry out the necessary examinations and appointments, and to declare consent after written and individual information has been provided.
  • The ability to give consent is checked by a physician who is not involved in the study.

Exclusion Criteria

  • \- Suicidality
  • \- History/evidence of brain surgery
  • \- Significant brain malformation or neoplasm
  • \- Head injury
  • \- Cerebral vascular events
  • \- Neurodegenerative disorder
  • \- Deep brain stimulation
  • \- Intracranial metallic particles
  • \- History of seizures
  • \- Diagnose of substance dependence or abuse as primary clinical problem

Outcomes

Primary Outcomes

Not specified

Similar Trials